Sign in
4

Changes in Ownership

Opus Genetics, Inc. Filed Acc 0001140361-18-003889

Options or other derivatives

  • Chief Medical Officer acquired 45,443 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Benaim Ely · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-01-26 Grant or award : show line 1 in the form Stock Option (right to buy) +45,443 $2.29 2028-01-26 45,443 45,443 D
Loading xslF345X03/form4.xml…